AOM (7.5 mg/kg body weight) is then injected into 10-week-old CDX2P-Cre-Apc+/LoxP mice, and these mice can develop 4–5 colon tumors at week 15 with no visible tumors in the small intestine [24]. This evidence concerns the gene APC and colonic neoplasm.